When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Karyopharm +4.0% after selinexor `encouraging clinical activity' in myeloma
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics (NASDAQ:KPTI) gains 4.0% in premarket trading after presenting new and updated data from its Phase 1b/2 STOMP study evaluating selinexor and dexamethasone in combination with standard approved multiple myeloma therapies in patients with previously treated multiple myeloma.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news,